SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-031148
Filing Date
2022-11-09
Accepted
2022-11-09 17:04:17
Documents
15
Period of Report
2022-11-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 50388
2 ex5-1.htm EX-5.1 14620
3 ex5-1_001.jpg GRAPHIC 5263
4 ex5-1_002.jpg GRAPHIC 13129
  Complete submission text file 0001493152-22-031148.txt   268048

Data Files

Seq Description Document Type Size
5 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sonn-20221109.xsd EX-101.SCH 3230
6 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sonn-20221109_lab.xml EX-101.LAB 34240
7 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sonn-20221109_pre.xml EX-101.PRE 22361
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3615
Mailing Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540
Business Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540 609-375-2227
Sonnet BioTherapeutics Holdings, Inc. (Filer) CIK: 0001106838 (see all company filings)

IRS No.: 522102141 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35570 | Film No.: 221373583
SIC: 2834 Pharmaceutical Preparations